G(I2) AND G(I3) PROTEINS MEDIATE THE INHIBITION OF ADENYLYL-CYCLASE BY GALANIN IN THE RINM5F CELL

Citation
Am. Mcdermott et Gwg. Sharp, G(I2) AND G(I3) PROTEINS MEDIATE THE INHIBITION OF ADENYLYL-CYCLASE BY GALANIN IN THE RINM5F CELL, Diabetes, 44(4), 1995, pp. 453-459
Citations number
37
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
Journal title
ISSN journal
00121797
Volume
44
Issue
4
Year of publication
1995
Pages
453 - 459
Database
ISI
SICI code
0012-1797(1995)44:4<453:GAGPMT>2.0.ZU;2-7
Abstract
Inhibition of adenylyl cyclase activity is one of at least four mechan isms by which the neuropeptide galanin inhibits insulin secretion from pancreatic beta-cells. In a membrane preparation of the insulin-secre ting cell Line RINm5F, a maximally effective concentration of galanin inhibited forskolin-stimulated adenylyl cyclase activity by 30%. Pretr eatment of the cells with pertussis toxin abolished the inhibitory eff ect of galanin, indicating the involvement of G(i) or G(o) guanine nuc leotide binding proteins (G-proteins). Because Galanin receptors inter act with four G-proteins (G(i1),G(i2),G(i3), and G(ol)), any or all of these may inhibit adenylyl cyclase. Therefore, to identify the G-prot ein(s) involved, antibodies raised against various G-protein alpha-sub units were used to block the inhibition of forskolin-stimulated adenyl yl cyclase activity by galanin in RINm5F membrane preparations. Antise ra AS/7 and EC/2, specific for G alpha(i1)/alpha(i2) and G alpha(i3), respectively, were able to significantly attenuate the inhibitory effe ct of Galanin, whereas antisera specific for G(o) proteins were not. T he use of additional antisera specific for the various subtypes of G(i ) proteins indicated that G(i2) and G(i3), but not G(i1), are involved . Simultaneous application of antisera AS/7 and EC/2 resulted in a gre ater attenuation of the effect of galanin than application of either a ntiserum alone. Thus, galanin inhibition of adenylyl cyclase activity in these cells is selectively mediated by two inhibitory G-proteins, G (i2) and G(i3).